Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03257202 · ClinicalTrials.gov registry record · Phase 2
Topical Treatment and Prevalence of P. Acnes
A Phase 2 study of Surgical Site Infection, sponsored by University of Southern California.
- Completed
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT03257202 is a Phase 2 study of Surgical Site Infection that has completed, run by University of Southern California. The registered enrollment target is 12 participants, below the 568-participant average among 25 other Surgical Site Infection trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03257202, a Phase 2 study of Surgical Site Infection, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is about preventing surgical site infections of the shoulder. We hope to learn if clindamycin alone, benzoyl peroxide alone, or clindamycin and benzoyl peroxide together can affect growth of Propionibacterium acnes in the dermal layer.
Conditions Studied
Interventions
- DRUG Clindamycin 1% Gel
- DRUG Benzoyl peroxide 5% gel
- DRUG BenzaClin 5%-1% Topical Gel
Study Locations (1)
California
- Keck School of Medicine of the University of Southern California - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-09-11 |
| Est. Completion | 2018-01-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03257202
The ClinicalTrials.gov registry entry for NCT03257202 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 568-participant average among 25 other Surgical Site Infection trials with a reported enrollment target (98% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Surgical Site Infection appearing as the primary indexed condition, and to 3 interventions - of which Clindamycin 1% Gel is the first listed.
NCT03257202 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03257202 about?
NCT03257202 is a clinical study titled "Topical Treatment and Prevalence of P. Acnes". This study is about preventing surgical site infections of the shoulder. We hope to learn if clindamycin alone, benzoyl peroxide alone, or clindamycin and benzoyl peroxide together can affect growth of Propionibacterium acnes in the dermal layer.
What is the current status of trial NCT03257202?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2017-09-11. Estimated completion is 2018-01-01.
What conditions does trial NCT03257202 study?
This clinical trial studies the following conditions: Surgical Site Infection.
What interventions are being tested in trial NCT03257202?
The interventions under investigation include: Clindamycin 1% Gel (DRUG), Benzoyl peroxide 5% gel (DRUG), BenzaClin 5%-1% Topical Gel (DRUG).
Who is sponsoring clinical trial NCT03257202?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03257202 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgical Site Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection
COMPLETED · Phase 2
-
Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ (ZX-ZP-0055)
COMPLETED · Phase 2
-
Zinc Oxide Versus Petrolatum Following Skin Surgery
RECRUITING · Early Phase 1
-
Diluted Aqueous Povidone-Iodine Compared to Saline to Decrease Surgical Site Infections
RECRUITING · Phase 3
-
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
RECRUITING · Phase 4
-
Studying How Outpatient Water affEcts Risks With Drains (SHOWER Study)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.